As of April 16, 2025, Day One Biopharmaceuticals (DAWN) has a market cap of $0.73 billion USD. According to our data, Day One Biopharmaceuticals is ranked No.5473 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.73 B |
-42.97%
|
Dec 31, 2024 | $1.28 B |
-13.22%
|
Dec 29, 2023 | $1.47 B |
-32.16%
|
Dec 30, 2022 | $2.17 B |
27.72%
|
Dec 31, 2021 | $1.70 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Blueprint Medicines
BPMC
|
$5.21 B |
0.000 M
|
![]() USA
|
![]() Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
![]() USA
|
![]() Kura Oncology
KURA
|
$0.49 B |
0.000 M
|
![]() USA
|
![]() Zymeworks
ZYME
|
$0.76 B |
-0.000 M
|
![]() Canada
|
![]() Relay Therapeutics
RLAY
|
$0.47 B |
-0.000 M
|
![]() USA
|
![]() Revolution Medicines
RVMD
|
$6.75 B |
0.000 M
|
![]() USA
|
![]() Cogent Biosciences
COGT
|
$0.55 B |
-0.000 M
|
![]() USA
|
![]() Foghorn Therapeutics
FHTX
|
$0.20 B |
0.000 M
|
![]() USA
|
![]() Erasca
ERAS
|
$0.34 B |
-0.000 M
|
![]() USA
|
Market Cap | = | DAWN Stock Price | * | DAWN Shares Outstanding |
= | $7.19 | * | 0.10 B | |
= | $0.73 B |